Table 1.

MCMC-based estimates of various tumor promotion and progression time scales

T1 (95% CI)Embedded Image (95% CI)T2 (95% CI)Tlag (95% CI)
Males
CRC32.6 (30.4–36.8)50.6 (49.7–52.1)5.2 (3.6–6.2)5.4 (3.1–7.0)
GaC17.9 (13.6–22.3)45.8 (43.8–47.9)12.2 (9.8–14.7)9.5 (7.7–12.0)
PaC49.1 (40.4–52.6)52.3 (50.9–52.9)0.7 (0.4–2.2)3.0 (0.2–6.8)
EAC15.0 (7.2–24.7)39.2 (34.2–44.0)12.0 (6.3–16.8)12.7 (3.1–16.5)
Females
CRC27.5 (25.1–30.5)48.7 (47.6–49.9)6.5 (5.2–7.6)6.5 (5.1–8.2)
GaC20.1 (16.8–23.4)58.6 (56.8–60.5)11.7 (10.1–13.2)10.6 (9.1–11.7)
PaC53.2 (44.7–56.7)56.3 (55.2–57.1)0.6 (0.4–1.8)1.7 (0.1–4.9)
EAC15.8 (13.8–18.4)37.9 (31.8–45.1)10.6 (7.8–13.8)10.2 (7.2–13.2)

NOTE: Estimates represent medians and 95% credibility regions of the marginal posterior distribution for each quantity listed. All units are in years.

Abbreviations: GaC, gastric cancer; PaC, pancreatic cancer.